About In vitro ADMET
In vitro ADMET is a Healthcare company based in Columbia (United States) founded in 2004, and was acquired by Discovery Life Sciences in December 2021. In vitro ADMET services are provided via proprietary IdMOC assays. In vitro ADMET offers products and services including In Vitro ADMET Services. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and In Vitro Assays. Its legal entity is In Vitro ADMET Laboratories, Inc. Its competitors include Anabios, Kiyatec and Lucid Scientific; 3 of its 3 listed competitors have raised funding.
Company details
In vitro ADMET Laboratories was founded in 2004 and is based in Columbia, United States. Preclinical drug development is supported through in vitro drug metabolism and toxicity testing services. Proprietary IdMOC technology is utilized to model multiple-organ interactions for evaluating drug and metabolite effects in applications like cancer screening. A range of ADMET assays is offered, alongside products such as cryopreserved hepatocytes and 3D Hep-I-Spheres for spheroid cultures.
- Headquarters Columbia, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website invitroadmet.com
- Social LinkedIn X Facebook
- Acquired by Discovery Life Sciences (Dec 2021)
- Legal Name In Vitro Admet Laboratories, Inc.
- Latest Funding Round$100K (USD), Grant
Sep 2011
- InvestorsHHS
& 1 more
- Acquired byDiscovery Life Sciences
(Dec 2021)
Products & Services of In vitro ADMET
In vitro ADMET offers a comprehensive portfolio of products and services, including In Vitro ADMET Services.
Evaluates drug absorption, metabolism, and toxicity properties
Funding Insights of In vitro ADMET
- Total Rounds 1
- Last Round Grant — $100,000
- First Round $100,000
(Sep 2011)
- Investors Count 1
All 1 funding rounds of In vitro ADMET with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2011 | $100,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in In vitro ADMET
In vitro ADMET has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Discovery Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Provider of diversified services with integrated technology platforms for drug discovery | 2006 | dls.com | Huntsville, United States |
Investor details for In vitro ADMET
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of In vitro ADMET
3 dated milestones of In vitro ADMET across 17 years, from founding to its latest funding, stage changes and deals.
- Founded In vitro ADMET is founded.
- Funding First funding round of $100K.
- Exit Acquired by Discovery Life Sciences.
Competitors of In vitro ADMET
In vitro ADMET has 3 listed competitors in our database, 3 of them funded. They include Anabios, Kiyatec and Lucid Scientific.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| anabios.com | 2009 | San Diego, United States | $24.78M | 51 | Ex-vivo human tissue studies are performed for preclinical drug discovery. | |
| kiyatec.com | 2005 | Pendleton, United States | $29.49M | Kiyatec is focused on revolutionizing cancer care through predictive platforms. | ||
| lucidsci.com | 2012 | Atlanta, United States | $12.73M | Real-time cell analyzers are developed for oxygen consumption monitoring. |
Detailed competitors of In vitro ADMET
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of In vitro ADMET
The website of In vitro ADMET (invitroadmet.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 25.6% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as In vitro ADMET (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about In Vitro Admet
Complete news archive for In vitro ADMET
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about In vitro ADMET
In vitro ADMET was founded in 2004 and raised its 1st funding round 7 years after it was founded.
In vitro ADMET is headquartered in Columbia, United States.
In vitro ADMET Laboratories was founded in 2004 and is based in Columbia, United States. Preclinical drug development is supported through in vitro drug metabolism and toxicity testing services. Proprietary IdMOC technology is utilized to model multiple-organ interactions for evaluating drug and metabolite effects in applications like cancer screening. A range of ADMET assays is offered, alongside products such as cryopreserved hepatocytes and 3D Hep-I-Spheres for spheroid cultures.
In vitro ADMET's top competitors include Kiyatec, Anabios and Lucid Scientific.
In vitro ADMET offers In Vitro ADMET Services.
In vitro ADMET has 2 investors. Key investors include HHS, and Discovery Life Sciences.
In vitro ADMET operates through In Vitro Admet Laboratories, Inc..
Yes. In vitro ADMET was acquired by Discovery Life Sciences in December 2021.